Why is Ajanta Pharma falling/rising?

As of 22-Jul, Ajanta Pharma Ltd. is currently priced at 2,730.70, reflecting a decline of 37.15 points or 1.34%. The stock has been underperforming, having fallen for the last three consecutive days, resulting in a total decrease of 2.48% during this period. Additionally, the stock's delivery volume has significantly decreased by 88.92% compared to the five-day average, indicating a drop in investor participation. Despite this recent downturn, Ajanta Pharma has shown strong performance over the past year, with a return of 17.96%, which is notably higher than the market's average return of 2.09%. The company also maintains a high management efficiency with a return on equity of 22.06% and a low debt-to-equity ratio, which are positive indicators for its financial health.
In the broader market context, Ajanta Pharma's recent performance contrasts with the benchmark Sensex, which has seen a slight decline of 0.47% over the past week. While Ajanta Pharma has outperformed the benchmark in the longer term, with a 5.72% increase over the past month compared to the Sensex's 0.27% decline, the current short-term trend suggests a struggle against market pressures. The stock's liquidity remains adequate for trading, but the recent drop in delivery volume and consecutive price falls may indicate a cautious sentiment among investors, despite the company's strong fundamentals and institutional backing.